SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-088279
Filing Date
2017-03-20
Accepted
2017-03-20 08:09:05
Documents
17
Period of Report
2017-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d349376d8k.htm 8-K 64380
2 EX-2.1 d349376dex21.htm EX-2.1 510112
3 EX-2.2 d349376dex22.htm EX-2.2 188787
4 EX-2.3 d349376dex23.htm EX-2.3 185280
5 EX-3.1 d349376dex31.htm EX-3.1 3103
6 EX-10.1 d349376dex101.htm EX-10.1 98702
7 EX-10.2 d349376dex102.htm EX-10.2 71634
8 EX-10.3 d349376dex103.htm EX-10.3 30978
9 EX-10.4 d349376dex104.htm EX-10.4 43572
10 EX-10.5 d349376dex105.htm EX-10.5 42133
11 EX-10.6 d349376dex106.htm EX-10.6 42220
12 EX-99.1 d349376dex991.htm EX-99.1 17777
13 GRAPHIC g349376exglogo.jpg GRAPHIC 9227
14 GRAPHIC g349376g0319224559489.jpg GRAPHIC 3200
15 GRAPHIC g349376g0319224600705.jpg GRAPHIC 3265
16 GRAPHIC g349376g0319224600752.jpg GRAPHIC 3265
17 GRAPHIC g349376logo.jpg GRAPHIC 9227
  Complete submission text file 0001193125-17-088279.txt   1339864
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 17700097
SIC: 2834 Pharmaceutical Preparations